Physician profile
Atul K Patel
NPI 1740321884
$95,712.13
in general payments reported to CMS, 2019-2025
48 companies · $27K in 2025
The $27K reported for 2025 was more than what 92% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $269 · 2021: $4,541 · 2022: $16K · 2023: $3,115 · 2024: $1,934 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Consulting Fee: $13K · Food and Beverage: $4,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,836.10 |
| Consulting Fee | $13,000.00 |
| Food and Beverage | $4,612.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $90,600.72 | 2019-2025 | Perla Tl, Perla Tl Mis, Cure Acp |
| Spineart Sa | $1,867.62 | 2019-2022 | |
| Alphatec Spine, INC | $459.16 | 2021-2022 | |
| Spineology INC. | $355.79 | 2023 | Optimesh Expandable Interbody Fusion System |
| Integra Lifesciences Corporation | $215.28 | 2021-2023 | Codman Certas, Cusa Clarity, Codman Hakim |
| Neurocrine Biosciences, INC. | $187.26 | 2019-2024 | Ingrezza, Ongentys |
| Orthofix Medical, INC. | $184.77 | 2024 | Spinal-Stim, Cervical-Stim |
| Corelink, LLC | $164.69 | 2022 | |
| Pfizer INC. | $139.31 | 2023-2024 | |
| Abbvie INC. | $131.34 | 2022-2023 | |
| Lundbeck LLC | $98.58 | 2022-2023 | Vyepti |
| Janssen Pharmaceuticals, INC | $94.55 | 2022 | |
| Argenx US, INC. | $88.35 | 2023 | Vyvgart, Vyvgart Hytrulo |
| Sk Life Science, INC. | $76.08 | 2023-2024 | |
| Revance Therapeutics, INC. | $60.64 | 2024 | Daxxify |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.